These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38971361)

  • 1. A case-cohort study of per- and polyfluoroalkyl substance concentrations and incident prostate cancer in the cancer prevention Study-II LifeLink cohort study.
    Troeschel AN; Teras LR; Hodge JM; Rodriguez J; Wang Y; Daniel J; Diver WR; Winquist A
    Environ Res; 2024 Oct; 259():119560. PubMed ID: 38971361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-Cohort Study of the Association between PFAS and Selected Cancers among Participants in the American Cancer Society's Cancer Prevention Study II LifeLink Cohort.
    Winquist A; Hodge JM; Diver WR; Rodriguez JL; Troeschel AN; Daniel J; Teras LR
    Environ Health Perspect; 2023 Dec; 131(12):127007. PubMed ID: 38088576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA copy number mediated the associations between perfluoroalkyl substances and breast cancer incidence: A prospective case-cohort study.
    Feng Y; You Y; Li M; Guan X; Fu M; Wang C; Xiao Y; He M; Guo H
    Sci Total Environ; 2024 Sep; 941():173767. PubMed ID: 38844220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
    Park SK; Wang X; Ding N; Karvonen-Gutierrez CA; Calafat AM; Herman WH; Mukherjee B; Harlow SD
    Diabetologia; 2022 Jul; 65(7):1157-1168. PubMed ID: 35399113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to per- and polyfluoroalkyl substances and age-related macular degeneration in U.S. middle-aged and older adults.
    Kang H; Park SK; Kim DH; Choi YH
    Chemosphere; 2024 Sep; 364():143167. PubMed ID: 39181460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
    Calafat AM; Wong LY; Kuklenyik Z; Reidy JA; Needham LL
    Environ Health Perspect; 2007 Nov; 115(11):1596-602. PubMed ID: 18007991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the impact of polyfluoroalkyl substance exposure on erythrocyte profiles and its related nutrients: Insights from a prospective study on young Taiwanese.
    Lin CY; Lee HL; Wang C; Sung FC; Su TC
    Environ Pollut; 2024 Oct; 359():124576. PubMed ID: 39032552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFAS Levels, Early Life Factors, and Mammographic Breast Density in Premenopausal Women.
    Ning YS; Getz KR; Kyeyune JK; Jeon MS; Luo C; Luo J; Toriola AT
    Environ Health Perspect; 2024 Sep; 132(9):97008. PubMed ID: 39292675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of per- and polyfluorinated substances and risk of B-cell non-Hodgkin lymphoma.
    Rhee J; Koponen J; Sampson JN; Keil AP; Ward MH; Hofmann JN; Huang WY; Silverman DT; Rantakokko P; Purdue MP
    Environ Int; 2024 Oct; 192():109058. PubMed ID: 39388845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water.
    Barton KE; Starling AP; Higgins CP; McDonough CA; Calafat AM; Adgate JL
    Int J Hyg Environ Health; 2020 Jan; 223(1):256-266. PubMed ID: 31444118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Sanchez-Guerra M; Osorio-Yáñez C; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105217. PubMed ID: 32086073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Analysis of Per- and Polyfluoroalkyl Substances from Early Pregnancy to Delivery in the Atlanta African American Maternal-Child Cohort.
    Tan Y; Eick SM; Dunlop AL; Barr DB; Taibl KR; Steenland K; Kannan K; Robinson M; Chang CJ; Panuwet P; Yakimavets V; Marsit CJ; Ryan PB; Liang D
    Environ Health Perspect; 2024 Nov; 132(11):117001. PubMed ID: 39504273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends of per- and polyfluoroalkyl substances concentrations: Insights from Australian human biomonitoring 2002-2021 and the U.S. NHANES programs 2003-2018.
    Taucare G; Chan G; Nilsson S; Toms LL; Zhang X; Mueller JF; Jolliet O
    Environ Res; 2024 Dec; 262(Pt 1):119777. PubMed ID: 39155039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.